PHILIPPINE Drug Enforcement Agency chair Director General Aaron N. Aquino yesterday ordered an
intensified inspections of over 5,000 pharmaceutical and chemical establishments to prevent
diversion of legitimate substances for illegal purposes specifically the clandestine production of
Aquino said the inspection will involve all Regulatory Compliance Officers of the PDEA
Compliance Service, a certified ISO 9001:2008 Quality Management System. For Regional Compliance
Units, each RCO is required to conduct at least four monthly inspections.
He added that the PDEA, through its Compliance Service headed by Director Helen Maita Reyes,
exercises regulatory functions to include the processing and issuance of licenses and permits to
pharmaceutical and chemical establishments engaged in the importation, distribution, manufacture,
prescription, dispensing and selling, and other lawful acts in connection with any dangerous drugs,
controlled precursors and essential chemicals (CPECs) and other similar substances.
“This is to determine the compliance of our regulated parties such as corporations,
institutions, individuals and other legal entities with the terms and conditions of any license or
permit granted pursuant to Republic Act 9165, otherwise known as the Comprehensive Dangerous Drugs
Act of 2002, and other implementing rules and regulations enforced by the Agency,” Aquino explained.
According to Aquino, records show that there are 5,427 registered pharmaceutical and
chemical entities handling dangerous drugs and CPECs in the country in 2017.
“These entities will be targeted for compliance inspections,” he said.
The PDEA chief said that to balance enforcement on chemical diversion control, regulatory
information advocacies are also being undertaken by PDEA-Compliance Service/Units through meetings
and conduct of seminar-workshops to stakeholders in collaboration with the Chemical and
Pharmaceutical Industry Organization of the Philippines Inc.